ARCHIVES

NDA For MeCCNU Turned Down By Oncologic Drugs Advisory Committee

This article is from The Cancer Letter archive.

Vol. 02 No. 36 | September 3, 1976

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

October 20, 1995

NCAB Member David Koch Gives $100 Million To MIT For New Cancer Research Institute.

October 12, 2007

DCCP Board Okays Noncompetitive Procurements

June 11, 1982

First Lady Recalls 1992 Meeting With NBCC, Credits Group For Progress In Breast Cancer

May 8, 1998

Genetic Risk Factor Implicated In Prostate Cancer In Blacks

August 25, 2006

NCI to release RFP for Cancer Information Service recompetition.

November 28, 2003